Press Releases |

25.10.2022

BRAIN Biotech and Bonumose collaborate on enzymes for the production of rare monosaccharides

Corporate Technology

Show Article

27.09.2022

Change in the Executive Management Board of BRAIN Biotech AG, genome editing activities established under the Akribion Genomics brand

Corporate

Show Article

26.09.2022

BRAIN Biotech AG sells subsidiary L.A. Schmitt to a URI group company

Corporate

Show Article

29.08.2022

BRAIN Biotech AG: On Track to Reach Financial Year 2021/22 Targets, 9M Reporting

Finance

Show Article

20.06.2022

BRAIN Biotech publishes first ESG and Sustainability Report

Corporate

Show Article

30.05.2022

BRAIN Biotech AG: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting

Finance

Show Article

30.05.2022

Prof. Dr Bernhard Hauer leaves Supervisory Board of BRAIN Biotech AG for personal reasons

Corporate

Show Article

04.04.2022

Successful Genome Editing in Mammalian Cells with BRAIN-Metagenome-Cas (BMC), BRAIN-Engineered-Cas (BEC)

Technology

Show Article

09.03.2022

Resolutions of the Annual General Meeting for the Fiscal Year 2020/2021 of BRAIN Biotech AG

Corporate Finance

Show Article